Immix Biopharma Inc (IMMX) — Financial Flexibility Index
Immix Biopharma Inc (IMMX) has a Financial Flexibility Index of -1.15x as of June 2026. Free cash flow of $-11.71 Million (operating CF $-11.74 Million minus capex $21.04K) represents -1% of total liabilities ($10.19 Million). Check Immix Biopharma Inc (IMMX) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Immix Biopharma Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Immix Biopharma Inc across 7 annual periods. For the full cash flow conversion analysis, see Immix Biopharma Inc (IMMX) cash conversion ratio.
Annual Financial Flexibility Index for Immix Biopharma Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Immix Biopharma Inc. Explore debt repayment capacity of Immix Biopharma Inc to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.10x | $-23.20 Million | $-23.93 Million | $11.04 Million | ▼ -51.8% |
| 2024 | -1.38x | $-13.42 Million | $-14.60 Million | $9.70 Million | ▲ +54.5% |
| 2023 | -3.04x | $-11.32 Million | $-11.37 Million | $3.72 Million | ▲ +28.2% |
| 2022 | -4.24x | $-7.41 Million | $-7.41 Million | $1.75 Million | ▲ +46.1% |
| 2021 | -7.86x | $-1.59 Million | $-1.59 Million | $202.04K | ▼ -10139.0% |
| 2020 | -0.08x | $-404.69K | $-404.69K | $5.27 Million | ▲ +55.0% |
| 2019 | -0.17x | $-782.72K | $-790.03K | $4.59 Million | — |